Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what estimate his Department has made of the number of relapsed blood cancer patients who will no longer be able to access second stem cell transplants as a result of the NHS England decision published on 11 July 2016 to no longer routinely fund second stem cell transplants for those patients.

The Clinical Priorities Advisory Group which makes recommendations to the Specialised Commissioning Oversight Group uses a defined process to prioritise treatments based on a combination of cost and patient benefit. The process includes an impact assessment that estimated that up to 22 patients per year by 2021 might be affected by this decision.